{
    "nctId": "NCT02963363",
    "briefTitle": "Adapted Physical Activity for Breast Cancer HER2 Positive Patient",
    "officialTitle": "Feasibility Study of an Adapted Physical Activity (APA) for Breast Cancer Patients Treated by Neoadjuvant Chemotherapy and Targeted Therapy Against HER2",
    "overallStatus": "TERMINATED",
    "conditions": "HER2 Positive Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 36,
    "primaryOutcomeMeasure": "Rate of patients reaching international physical activity recommendations for post-neoadjuvant chemotherapy assessment",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women \\> 18 years old\n* Patient with HER2 (Human Epidermal growth factor Receptor 2) positive breast cancer histologically proven, eligible for neoadjuvant chemotherapy and targeted therapy against HER-2\n* Affiliation to the French social security scheme\n* Patient who signed the participation consent before entering the trial\n* Medical fitness certificate for sport\n\nExclusion Criteria:\n\n* Diagnosis of a second malignancy in the past 5 years, with the exception of a basal cell skin cancer\n* Metastatic cancer\n* Karnofsky index \u2264 90%\n* Men\n* Pregnant women\n* Significant psychiatric or neurological abnormality\n* Patient deprived of liberty by a court or administrative\n* Contraindication for physical activity\n* Patient unable to complete questionnaires (language barrier)\n* Participation in a clinical trial with the same objective",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}